uniQure N.V. Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Noncurrent
uniQure N.V. (QURE) had Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Noncurrent of $39.98 million as of 2022-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Assets
us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLossNoncurrent · last filed 2024-02-28
- 2022-12-31: Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Noncurrent $39.98M.
| Period end | Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Noncurrent |
|---|---|
| 2022-12-31 | $39.98M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |